A novel role for programmed cell death receptor ligand-1 in sepsis-induced intestinal dysfunction

Molecular Medicine

Volumn 22, Issue , 2016, Pages 830-840

  Wu, Youping ^a   Chung, Chun Shiang ^b   Chen, Yaping ^b   Monaghan, Sean Farrell ^b   Patel, Sima ^c   Huang, Xin ^b   Heffernan, Daithi Seamus ^b   Ayala, Alfred ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRAMMED CELL DEATH RECEPTOR LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACO-2 CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROPATHY; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; MALE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; TISSUE SECTION; UPREGULATION;

EID: 85010417218     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2016.00150     Document Type: Article

References (49)

1. Angus DC, van der Poll T. (2013) Severe sepsis and septic shock. New Engl. J. Med. 369:840-51.
2. Boomer JS, et al. (2011) Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure. JAMA. 306:2594-605.
3. Heffernan DS, et al. (2012) Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit. Care. 16:R12.
4. Monneret G, Venet F, Pachot A, Lepape A. (2007) Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. 14:64-78.
5. Inoue S, et al. (2013) Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit. Care Med. 41:810-19.
6. Drewry AM, et al. (2014) Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality. Shock. 42:383-91.
7. Hotchkiss RS, Monneret G, Payen D. (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13:260-68.
8. Deitch EA. (2001) Role of the gut lymphatic system in multiple organ failure. Curr. Opin. Crit. Care. 7(2):92-98.
9. Fink MP. (2003) Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr. Opin. Crit. Care. 9:143-51.
10. Turner JR. (2009) Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9:799-809.
11. Zhu W, et al. (2013) PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model. Mediators Inflamm. 2013:361501.
12. Huang X, et al. (2014) Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J. Immunol. 192:1091-99.
13. Kanai T, et al. (2003) Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation. J. Immunol. 171:4156-63.
14. Chang K, et al. (2014) Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit. Care. 18:R3.
15. Nakazawa A, et al. (2004) The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology. 126:1347-57.
16. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8:239-45.
17. Wu YY, et al. (2010) Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection. Clin. Exp. Immunol. 161:551-59.
18. Scandiuzzi L, et al. (2014) Tissue-expressed B7-H1 critically controls intestinal inflammation. Cell Rep. 6:625-32.
19. Chung CS, et al. (2010) Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival. Shock. 34:150-61.
20. Zellweger R, Wichman MS, Ayala, A, Stein S, DeMaso CM, Chaudry IH. (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit. Care Med. 25:106-10.
21. Knöferl MW, et al. (2000) Do female sex steroids adversely or beneficially affect the depressed immune responses in males after trauma-hemorrhage? Arch. Surg. 135:425-33.
22. Hugunin KMS, Fry C, Shuster K NJ. (2010) Effects of tramadol and buprenorphine on select immunologic factors in a cecal ligation and puncture model. Shock. 34:250-60.
23. Guerra AS, et al. (2011) Anti-inflammatory and antinociceptive activities of indole-imidazolidine derivatives. Int. Immunopharmacol. 11:1816-22.
24. Chung CS, Xu YX, Wang W, Chaudry IH, Ayala A. (1998) Is Fas Ligand or Endotoxin Responsible for Mucosal Lymphocyte Apoptosis in Sepsis? Arch. Surg. 133:1213-20.
25. Mühlbauer M, et al. (2006) PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and-gamma and mediates T cell apoptosis. J. Hepatol. 45:520-28.
26. Wang W, Smail N, Wang P, Chaudry IH. (1998) Increased Gut Permeability after Hemorrhage Is Associated with Upregulation of Local and Systemic IL-6. J. Surg. Res. 79:39-46.
27. Sappington PL, et al. (2002) HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology. 123:790-802.
28. Suzuki T, Yoshinaga N, Tanabe S. (2011) Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J. Biol. Chem. 286:31263-71.
29. Madara JL. (1989) Loosening Tight Junctions. J. Clin. Invest. 83:1089-94.
30. Ma TY, et al. (2004) TNF-a-induced increase in intestinal epithelial tight junction permeability requires NF-kB activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G367-76.
31. Bruewer M, et al. (2003) Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171:6164-72.
32. Ulluwishewa D, et al. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 141:769-76.
33. Zolotarevsky Y, et al. (2002) A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 23:163-72.
34. Guignant C, et al. (2011) Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit. Care. 15:R99.
35. Huang X, et al. (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. U.S.A. 106:6303-38.
36. Zhang Y, et al. (2010) PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care. 14:R220.
37. Clayburgh DR, et al. (2005) Epithelial myosin light chain kinase dependent barrier dysfunction mediates T cell activation induced diarrhea in vivo. J. Clin. Invest. 115:2702-15.
38. Al-Sadi R, Boivin M, Ma T. (2009) Mechanism of cytokine modulation of epithelial tight junction barrier. Front. Biosci. 14:2765-78.
39. Simionescu M. (2007) Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol. 27:266-74.
40. Wang Q, Fang CH, Hasselgren P. (2001) Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R1013-23.
41. Wu R, et al. (2009) Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit. Care Med. 37:2421-26.
42. Fredenburgh LE, et al. (2011) Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. J. Immunol. 187:5255-67.
43. Yang J, et al. (2013) Heprim-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis. Surgery. 153:52-62.
44. Yoseph BP, et al. (2016) Mechanisms of intestinal barrier dysfunction in sepsis. Shock. 46:52-59.
45. Li Q, Zhang Q, Wang C, Liu X, Li N LJ. Distruption of tight junctions during polymicrobial sepsis. J. Pathol. 2009;218:210-21.
46. Ye D, Ma I, Ma TY. (2006) Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G496-504.
47. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. (2007) Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 27:111-22.
48. Ghiotto M, et al. (2010) PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int. Immunol. 22:651-60.
49. Miyauchi E, et al. (2013) Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules. PLoS. One. 8:e79735.